A Study to Assess Impulsivity and its Association with Post-Treatment Relapse in Subjects with Substance Use Disorders
Overview
Tab Title Description
Study type
ObservationalDescribes the nature of a clinical study. Types include:
- Observational study — observes people and measures outcomes without affecting results.
- Interventional study (clinical trial) — studies new tests, treatments, drugs, surgical procedures or devices.
- Medical records research — uses historical information collected from medical records of large groups of people to study how diseases progress and which treatments and surgeries work best.
Study IDs
Site IRB
- Rochester, Minnesota: 16-004312
Sponsor Protocol Number: 16-004312
About this study
Impulsivity is a major component of addictive behavior contributing to the initiation and perpetuation of Substance Use Disorders (SUDs). The purpose of this study is to investigate the correlation of self-reported measures of impulsivity, neurocognitive task measures of impulsivity, with craving intensity, the correlation of neurocognitive task measures of impulsivity, and the association between impulsivity measures and sequence variability in the A2AR gene.
Participation eligibility
Participant eligibility includes age, gender, type and stage of disease, and previous treatments or health concerns. Guidelines differ from study to study, and identify who can or cannot participate. There is no guarantee that every individual who qualifies and wants to participate in a trial will be enrolled. Contact the study team to discuss study eligibility and potential participation.
Inclusion Criteria:
- Primary diagnosis of any SUD as per DSM 5 criteria
- Able to understand English
- Consenting to be included in the study and for post-treatment follow up data collection by the IAP staff
Exclusion Criteria:
- Unable or unwilling to sign informed consent
- Psychiatrically or medically unstable as determined by study personnel Presence of moderate to severe alcohol withdrawal (Clinical Institute Withdrawal Assessment for Alcohol, CIWA score > 5)
- Taking medication for alcohol withdrawal that could affect informed consent
Participating Mayo Clinic locations
Study statuses change often. Please contact the study team for the most up-to-date information regarding possible participation.
More information
Publications
Publications are currently not available